Trial intelligence / Profile preview

Ferric Citrate vs Ferrous Sulfate in CKD with Iron Deficiency

NCT02888171Completed

Sponsor
University of Alabama at Birmingham
Start
Sep 2016
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of ferric citrate in iron deficiency anemia (IDA) and anemia (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoints: Change in Ferritin at 12 weeks and Change in Transferrin Saturation at 12 weeks. Started Sep 2016; status: completed.

02

Drugs

ferric citrate
03

Conditions

iron deficiency anemia (IDA)anemia

Beyond the preview

Go deeper on NCT02888171.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02888171.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call